Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Tough

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Trends in Immunology|May 4, 2005
Is RNA interference feasible for the control of foot-and-mouth disease outbreaks?Jagadeesh Bayry, David F Tough
Cytokine & Growth Factor Reviews|December 11, 2007
Type I interferon as a stimulus for cross-primingAgnès Le Bon, David F Tough
Current Opinion in Immunology|June 29, 2002
Links between innate and adaptive immunity via type I interferonAgnes Le Bon, David F Tough
Nature Immunology|January 21, 2006
'3d' effects on global immunityRobert W Carter, David F Tough
Epigenomics|December 8, 2016
Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic interventionDavid F Tough, Rab K Prinjha
Trends in Pharmacological Sciences|March 12, 2014
Targeting CCR4 as an emerging strategy for cancer therapy and vaccinesJagadeesh Bayry, Eric Tartour, David F Tough
Cytokine & Growth Factor Reviews|July 15, 2010
Regulation of immune cell homeostasis by type I interferonsFabrizio Mattei, Giovanna Schiavoni, David F Tough
Current Protocols in Immunology|April 25, 2008
Measurement of T and B cell turnover with bromodeoxyuridineDavid F Tough, Jonathan Sprent, Geoffrey L Stephens
Arthritis and Rheumatism|October 31, 2007
Do activated human dendritic cells diminish the suppressive functions of CD4+,CD25+ regulatory T cells? Comment on the article by van Amelsfort et alJagadeesh Bayry, Srini V Kaveri, David F Tough
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gammaArun T Kamath, Christopher E Sheasby, David F Tough
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Trends in Immunology|May 4, 2005
Is RNA interference feasible for the control of foot-and-mouth disease outbreaks?Jagadeesh Bayry, David F Tough
Cytokine & Growth Factor Reviews|December 11, 2007
Type I interferon as a stimulus for cross-primingAgnès Le Bon, David F Tough
Current Opinion in Immunology|June 29, 2002
Links between innate and adaptive immunity via type I interferonAgnes Le Bon, David F Tough
Nature Immunology|January 21, 2006
'3d' effects on global immunityRobert W Carter, David F Tough
Epigenomics|December 8, 2016
Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic interventionDavid F Tough, Rab K Prinjha
Trends in Pharmacological Sciences|March 12, 2014
Targeting CCR4 as an emerging strategy for cancer therapy and vaccinesJagadeesh Bayry, Eric Tartour, David F Tough
Cytokine & Growth Factor Reviews|July 15, 2010
Regulation of immune cell homeostasis by type I interferonsFabrizio Mattei, Giovanna Schiavoni, David F Tough
Current Protocols in Immunology|April 25, 2008
Measurement of T and B cell turnover with bromodeoxyuridineDavid F Tough, Jonathan Sprent, Geoffrey L Stephens
Arthritis and Rheumatism|October 31, 2007
Do activated human dendritic cells diminish the suppressive functions of CD4+,CD25+ regulatory T cells? Comment on the article by van Amelsfort et alJagadeesh Bayry, Srini V Kaveri, David F Tough
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gammaArun T Kamath, Christopher E Sheasby, David F Tough
Pageof 9